Collaborative Practice Agreement Certificate Program

This program will prepare pharmacists to enter into a written collaborative practice agreement (CPA) with a supervising physician in accordance with Florida law.

decor

Program Details

  • Intended Audience: Pharmacists who would like to enter into a Collaborative Practice Agreement
  • Universal Activity Number: 0012-0000-21-006-B04-P
  • Certificate Program Number: 0012-23-007-CP
  • Contact Hours: 20.0 hours of ACPE continuing education for pharmacists (12.0 hours self-paced; 8-live, online)
  • Program Fees:
    • Regular Registration: $549.00
    • UF Preceptor/Career Coach: $449.00
    • UF COP Faculty: $425.00
  • UAN Release Date: 01/29/2021
  • UAN Expiration Date: 01/29/2024
  • Activity Type: Practice/Certificate Program
  • Program Support: No outside financial support was provided.
  • Format Type: This course includes a 12.0 hour self-paced, fully online home study, as well as an 8.0 hour live session (hosted via Zoom). Learners will select their live session date by enrolling in one of the available course sections. 
  • Time to Complete: All coursework must be completed within 24 weeks from the date of registration or before date of UAN expiration, 01/29/2024, whichever comes first. This course will no longer be eligible for CE credit after 01/29/2024.

Summary

This program meets the requirements outlined in Section 465.1865, Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida.  Upon successful completion of the program, participants will earn a certificate of achievement from the University of Florida Office of Continuing Pharmacy Education. Visit the Florida Board of Pharmacy website to learn more about pharmacist requirements to enter into a Collaborative Practice Agreement.

Save the Date

Upcoming live sessions:

  • Saturday, March 2nd, 2024 | Zoom (8 a.m. – 5 p.m. Eastern)
  • Saturday, June 1st, 2024 | Zoom (8 a.m. – 5 p.m. Eastern)

Program Aims

Upon completion of the program the learner will be familiar with the legal and regulatory requirements associated with entering into a collaborative practice agreement, patient assessment and treatments for chronic diseases outlined in Florida law, be able to write a written collaborative practice agreement, and gain experience building a business model and marketing plan for their practice. For each of the health conditions listed below, the learner will be required to demonstrate the following competencies through interactive completion of live lectures, patient cases, and other active learning exercises:

  • Perform needed patient assessment skills
  • Develop and communicate plans for ordering, performing, and interpreting clinical and laboratory tests
  • Evaluate and develop treatment plans for collaborative practice and communicate these to patients and providers
  • List required follow up and documentation for collaborative practice 

Disease States Pharmacists Can Manage in a Collaborative Practice Agreements under Florida Board of Pharmacy Rules and Regulations:

Hypertension

Hyperlipidemia

Anticoagulation

Type 2 Diabetes

Obesity

Asthma

COPD

Nicotine Dependence

HIv/AIDs

Arthritis

Opioid-Use Disorder


Objectives

At the completion of this activity, the participant will be able to:

  • Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a Collaborative Practice Agreement in the State of Florida as outlined in Chapter 465 and Chapter 64B16-31.005.
  • Develop a pharmacist Collaborative Practice Agreement including all required elements of a Collaborative Practice Agreement and communications, documentation, and other pertinent subjects.
  • Describe the benefits and barriers to including pharmacists in interprofessional care teams while practicing under a Collaborative Practice Agreement.
  • Perform patient assessments, order, perform, and interpret clinical and laboratory tests related to Collaborative Pharmacy Practice, and evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioners.
  • Implement communication, documentation, and marketing strategies to secure and strengthen relationships with patients and providers.

Program Overview

Module 1: An Overview of Collaborative Practice Agreements in Florida

  • In this module we look at patient care in the ambulatory setting, components of collaborative practice agreements, and associated legal and professional practice requirements in the state of Florida.

Module 2: Treating and Managing Diseases and Health Conditions (Part 1)

  • In this module we will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:
    • Hyperlipidemia
    • Hypertension
    • Obesity
    • Anticoagulation
    • Nicotine Dependence

Module 3: Treating and Managing Diseases and Health Conditions (Part 2)

  • In this module we will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:
    • Type 2 Diabetes Mellitus
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Human Immunodeficiency Virus (HIV)
    • Arthritis
    • Substance Use Disorders and Opioid Reversal

Module 4: Establish and Implement Collaborative Agreements within the Practice

  • In this module we will discuss how to write a written collaborative practice agreement and building a business model and marketing plan for your practice. 

Requirements for Successful Course Completion

In order to earn credit for this course, participants complete the 12.0 hour home study material and pass a home study final assessment with a score of 70% or higher. Learners must also attend one, full 8.0 live session and pass a live seminar final assessment with a score of 70% or higher. Two chances to pass each assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.

Upon successful completion of the course components outlined above, learners will receive a certificate of completion which may be provided to the Florida Board of Pharmacy to apply for Collaborative Practice Agreement initial licensure.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.

The Zoom link and information for the virtual live session will be provided within the Canvas course.


Acknowledgements and Disclosures

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB (speaker) has disclosed that he receives an unrestricted Investigator-initiated Research Grant from BMS/Pfizer. All of the relevant financial relationships listed for Dr. Dietrich have been mitigated. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.

Advisory Board

Katie Vogel Anderson
Department: Pharmacotherapy & Translational Research

Katie Vogel Anderson Pharm.D., BCACP, FCCP

Teresa E Roane
Department: Pharmacotherapy & Translational Research

Teresa E Roane PharmD, MBA, BCACP

Eric Rosenberg
Department: Department of Internal Medicine

Eric Rosenberg MD, MSPH, FACP

Siegfried O Schmidt
Department: MD-CHFM SPRINGHILL

Siegfried O Schmidt MD, PhD

John Gums
Department: Pharmacotherapy & Translational Research

John Gums Pharm.D., FCCP

Rachel Shaddock
Department: Pharmacotherapy & Translational Research

Rachel Shaddock

Faculty

Eric A Dietrich
Department: Pharmacotherapy & Translational Research

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Gary Cacciatore
Department: Pharmacotherapy & Translational Research

Gary Cacciatore

Carol A Motycka
Department: Jacksonville Campus

Carol A Motycka Pharm.D., BCACP

Michelle Z Farland
Department: Pharmacotherapy & Translational Research

Michelle Z Farland Pharm.D.

Eric F Egelund
Department: Jacksonville Campus

Eric F Egelund Ph.D., Pharm.D.

Leslie Hendeles
Department: MD-PEDIATRICS

Leslie Hendeles Pharm.D.


What do our students have to say about Collaborative Practice?

I thoroughly enjoyed UF’s CPA Agreement class. I feel it has enhanced my knowledge of various chronic conditions that require medication management along with providing a great walkthrough on how to compose and market a CPA. I would certainly recommend it to any person who works in or wants to integrate themselves into a health care team setting“.

Damon Burkhart, PharmD, CPh, CDCES

CPA Infographic

Collaborative Practice Agreements in Action

Curious how a collaborative practice agreement can impact your practice? Check out the interviews below to see how our pharmacists are making a difference!

Interview with Neal Holland, D.O.

Interview with Ryan Nall, M.D.


Q: How does the Collaborative Practice Agreement certificate program compare to the Ambulatory Care certificate program?

  • The Collaborative Practice Agreement training program meets the requirements outlined by the State of Florida for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician. Health conditions covered in this program include those pharmacists are allowed to manage according to the Florida law plus incorporates elements of the Florida rules and regulations for establishing a collaborative practice agreement, business principles necessary to assist with development of a practice site, and guidance on drafting a collaborative practice agreement protocol. In addition, this program contains a self-study portion as well as a live, interactive portion to meet Florida law requirements.
  • The Ambulatory Care certificate training program is designed as a resource to help prepare the pharmacist provide patient-centered care in a wide variety of ambulatory care settings with the goal of improving patient outcomes. It is also designed to serve as a starting point to help the pharmacist prepare for the Ambulatory Care board certification exam. The health conditions covered may include those covered in the Collaborative Practice Agreement training program; however, additional disease states are included that are not covered. This program is self-paced and fully online.
  • Some of the content may overlap between the programs; however, they are structured differently and the content overall is different.

Please see the Collaborative Practice Agreement FAQ for more information.


Collaborative Practice Agreement Resources

Centers for Disease Control and Prevention

Increasing the Use of Collaborative Practice Agreements Between Prescribers and Pharmacists

Collaborative Practice Agreements and Pharmacists’ Patient Care Services

Advancing Team-Based Care Through Collaborative Practice Agreements

Florida Board of Pharmacy


Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.